Laura E. Wallace

Binger Str. 173
Ingelheim Am Rhein, RP 55216, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.

Journal: Advances in therapy

Published: October 18, 2021

Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.

Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.

Journal: Advances in therapy

Published: February 24, 2021

Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.

Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.

Journal: Advances in therapy

Published: November 20, 2020

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.

Journal: Advances in therapy

Published: October 14, 2020

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.

Journal: Rheumatology (Oxford, England)

Published: March 13, 2020

No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study.

No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study.

Journal: Scientific reports

Published: August 07, 2019

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease.

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease.

Journal: Clinical epidemiology

Published: October 19, 2018

Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.

Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.

Journal: BMC pulmonary medicine

Published: July 06, 2018

The epidemiology of outpatient pain treatment in pediatrics.

The epidemiology of outpatient pain treatment in pediatrics.

Journal: Journal of pain research

Published: May 17, 2018

Buprenorphine transdermal system utilization.

Buprenorphine transdermal system utilization.

Journal: Postgraduate medicine

Published: December 01, 2016

ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.

ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.

Journal: Pain medicine (Malden, Mass.)

Published: July 05, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026